{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:14:13Z","timestamp":1792804453639,"version":"4.5.0"},"reference-count":79,"publisher":"SAGE Publications","issue":"9-10","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Tissue Engineering Part A"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>\n                    In light of the current novel coronavirus (COVID-19) pandemic, as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on the application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well suited to apply their skill set to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers, and highlights important developments in the field of tissue engineering relevant to the current pandemic, including\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    model systems, vaccine technology, and small-molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines, and tissue engineers are well trained to be leaders and contributors in this time of need.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Impact statement<\/jats:title>\n                    <jats:p>Given the steep mortality caused by the recent novel coronavirus (COVID-19) pandemic, there is clear need for advances in diagnostics and therapeutics for viral outbreaks. Tissue engineering has the potential for critical impact on clinical outcomes in viral outbreaks. Tissue engineers, if mobilized, could play key roles as leaders in the outbreak, given their ability to apply engineering principles to biological processes, experience in collaborative environments, and penchant for technological translation from benchtop to bedside. In this work, three areas pioneered by tissue engineers that could be applied to the current COVID-19 crisis and future viral outbreaks are highlighted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/ten.tea.2020.0094","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T01:14:41Z","timestamp":1586481281000},"page":"468-474","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":41,"title":["Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks"],"prefix":"10.1177","volume":"26","author":[{"given":"Alexander M.","family":"Tatara","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"World Health Organization. Coronavirus disease (COVID-19) pandemic. World Health Organization 2020."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1011.040729"},{"key":"e_1_3_4_4_2","article-title":"Assessing the international spreading risk associated with the 2014 West African Ebola outbreak","volume":"6","author":"Gomes M.F.","year":"2014","unstructured":"Gomes M.F., , y Piontti A.P., , Rossi L., et al. Assessing the international spreading risk associated with the 2014 West African Ebola outbreak. PLoS Curr, 6, 2014.","journal-title":"PLoS Curr"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30623-7"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.02.006"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.5056188"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2015.10.059"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2016.03.009"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.123"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201201762"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","unstructured":"Tatara A.M. Ratcliffe A. Wong M.E. Kasper F.K. and Mikos A.G. Biomaterials in regenerative medicine: considerations in early process development. In: Translational Regenerative Medicine. Elsevier 2015 p. 141.","DOI":"10.1016\/B978-0-12-410396-2.00012-8"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2018.0138"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","unstructured":"Chatterjee S. Understanding the nature of variations in structural sequences coding for coronavirus spike envelope membrane and nucleocapsid proteins of SARS-CoV-2 (March 28 2020).","DOI":"10.2139\/ssrn.3562504"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","unstructured":"Fehr A.R. and Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: Coronaviruses. Springer 2015 p. 1.","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","unstructured":"Zheng Y.-Y. Ma Y.-T. Zhang J.-Y. and Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020 [Epub ahead of print]; DOI: 10.1038\/s41569-020-0360-5.","DOI":"10.1038\/s41569-020-0360-5"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-00240-0"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2001737"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","unstructured":"Pedersen S.F. and Ho Y.-C. SARS-CoV-2: a storm is raging. J Clin Invest 2020 [Epub ahead of print]; DOI: 10.1172\/JCI137647.","DOI":"10.1172\/JCI137647"},{"key":"e_1_3_4_20_2","volume-title":"Allergy","author":"Zhang J.J.","year":"2020","unstructured":"Zhang J.J., , Dong X., , Cao Y.Y., et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy, 2020 [Epub ahead of print]; DOI: 10.1111\/all.14238."},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","unstructured":"Lippi G. and Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020 [Epub ahead of print]; DOI: 10.1515\/cclm-2020-0198.","DOI":"10.1515\/cclm-2020-0198"},{"key":"e_1_3_4_22_2","author":"To K.K.-W.","unstructured":"To K.K.-W., , Tsang O.T.-Y., , Leung W.-S., et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020 [Epub ahead of print]; DOI: 10.1016\/S1473-3099(20)30196-1.","journal-title":"et al"},{"key":"e_1_3_4_23_2","author":"Yang X.","unstructured":"Yang X., , Yu Y., , Xu J., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020 [Epub ahead of print]; DOI: 10.1016\/S2213-2600(20)30079-5.","journal-title":"et al"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","unstructured":"Remuzzi A. and Remuzzi G. COVID-19 and Italy: what next? Lancet 2020 [Epub ahead of print]; DOI: 10.1016\/S0140-6736(20)30627-9.","DOI":"10.1016\/S0140-6736(20)30627-9"},{"key":"e_1_3_4_25_2","author":"Xie J.","unstructured":"Xie J., , Hungerford D., , Chen H., et al. Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19. medRxiv 2020 [Epub ahead of print]; DOI: 10.1101\/2020.03.28.20045997.","journal-title":"et al"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.11.018"},{"key":"e_1_3_4_27_2","first-page":"290ra89","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti\u2013Ebola virus activity","volume":"7","author":"Johansen L.M.","year":"2015","unstructured":"Johansen L.M., , DeWald L.E., , Shoemaker C.J., et al. A screen of approved drugs and molecular probes identifies therapeutics with anti\u2013Ebola virus activity. Scince Transl Med, 7, 290ra89, 2015.","journal-title":"Scince Transl Med"},{"key":"e_1_3_4_28_2","author":"Jeon S.","unstructured":"Jeon S., , Ko M., , Lee J., et al. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. bioRxiv 2020 [Epub ahead of print]; DOI: 10.1101\/2020.03.20.999730.","journal-title":"et al"},{"key":"e_1_3_4_29_2","author":"Ziegler C.","unstructured":"Ziegler C., , Allon S.J., , Nyquist S.K., et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is enriched in specific cell subsets across tissues. Cell 2020 [Epub ahead of print]; DOI: 10.2139\/ssrn.3555145.","journal-title":"et al"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06179-y"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-006-5437-9"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004249"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2017.0449"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.3390\/v8110304"},{"key":"e_1_3_4_35_2","volume-title":"et al","author":"Suderman M.","unstructured":"Suderman M., , McCarthy M., , Mossell E., et al. Three-dimensional human bronchial-tracheal epithelial tissue-like assemblies (TLAs) as hosts for severe acute respiratory syndrome (SARS)-CoV infection. NASA\/TP-2006-213723. NASA, 2006."},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510232103"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00041.2016"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/scrt368"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16506-9"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1280"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119308"},{"key":"e_1_3_4_42_2","author":"Emanuel E.J.","unstructured":"Emanuel E.J., , Persad G., , Upshur R., et al. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med 2020 [Epub ahead of print]; DOI: 10.1056\/NEJMsb2005114.","journal-title":"et al"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22211.2"},{"key":"e_1_3_4_44_2","author":"Gautret P.","unstructured":"Gautret P., , Lagier J.-C., , Parola P., et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020 [Epub ahead of print]; DOI: 10.1016\/ijantimicag.2020.105949.","journal-title":"et al"},{"key":"e_1_3_4_45_2","author":"Kim A.H.","unstructured":"Kim A.H., , Sparks J.A., , Liew J.W., et al. A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19. Ann Intern Med 2020 [Epub ahead of print]; DOI: 10.7326\/M20-1223.","journal-title":"et al"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.04.081"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.01.022"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03439.x"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2009.0655"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910993"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1729069"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.matlet.2014.05.110"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.10.010"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau2277"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350400900310"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2014.09.003"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.291"},{"key":"e_1_3_4_58_2","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Demicheli V.","year":"2018","unstructured":"Demicheli V., , Jefferson T., , Ferroni E., , Rivetti A., , and Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev, 2, CD001269, 2018.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000777"},{"key":"e_1_3_4_60_2","doi-asserted-by":"crossref","unstructured":"Poole P.J. Chacko E. Wood-Baker R.W. and Cates C.J. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev CD002733 2006.","DOI":"10.1002\/14651858.CD002733.pub2"},{"key":"e_1_3_4_61_2","doi-asserted-by":"crossref","unstructured":"Chen W.H. Strych U. Hotez P.J. and Bottazzi M.E. The SARS-CoV-2 vaccine pipeline: an overview. Curr Trop Med Rep 2020 [Epub ahead of print]; DOI: 10.1007\/s40475-020-00201-6.","DOI":"10.1007\/s40475-020-00201-6"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/btpr.10"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.6b00027"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmat4290"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.01.026"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201603563"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1119346"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.04.021"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.11.073"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061135"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp4000053"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.11.068"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2008.00746.x"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.4161\/biom.1.1.16277"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000359"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3071"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0361-x"},{"key":"e_1_3_4_78_2","author":"Super M.","unstructured":"Super M., , Doherty E.J., , Cartwright M.J., et al. Modular biomaterials vaccine technology protects against multiple pathogens and septic shock. bioRxiv 2020 [Epub ahead of print]; DOI: 10.1101\/2020.02.25\/964601.","journal-title":"et al"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12966"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201507928"}],"container-title":["Tissue Engineering Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/ten.tea.2020.0094","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ten.tea.2020.0094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ten.tea.2020.0094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:51:49Z","timestamp":1777697509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/ten.tea.2020.0094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":79,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1089\/ten.tea.2020.0094"],"URL":"https:\/\/doi.org\/10.1089\/ten.tea.2020.0094","relation":{},"ISSN":["1937-3341","1937-335X"],"issn-type":[{"value":"1937-3341","type":"print"},{"value":"1937-335X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}